R.F. MAKHMUTOV, A.D. ISMAILOVA

Gorky Donetsk State Medical University, Donetsk

Contact details:

Makhmutov R.F. — MD, Professor of the Department of Pediatrics No. 2

Address: 16 prospekt Ilyicha, 283003 Donetsk, Donetsk People’s Republic, Russian Federation, tel.: +7-856-297-89-01, e-mail: ravilclassic@yandex.com

 The article presents a review of the Russian and foreign literature on the modern aspects of the clinical picture, diagnostics and treatment of irritable bowel syndrome in children. The prevalence of this syndrome in children demonstrates significant variability depending on the geographic region and characteristics of the studies conducted. Clinical manifestations may include difficulties with defecation, mucous secretions in the stool, flatulence, etc. The key conditions for diagnosis are the connection between these symptoms, especially abdominal pain, and defecation: relief after defecation and correlation of pain syndrome with changes in the frequency or consistency of stool. Diagnostics should be carried out in accordance with the recommendations of the Society of Pediatric Gastroenterologists and the Rome IV criteria. Treatment of irritable bowel syndrome in children should be carried out in parallel strategic lines: both non-drug (psychological correction, diet therapy) and drug treatment.

Key words: irritable bowel syndrome, clinical picture, diagnostics, treatment, children.

REFERENCES

1. Bel’mer S.V., Gurova M.M., Zvyagin A.A. et al. Irritable bowel syndrome in children: evolution of clinical guidelines. Eksperimental’naya i klinicheskaya gastroenterologiya, 2023, vol. 209, no. 1, pp. 98–107 (in Russ.).
2. Nardo G.D., Barbara G., Borrelli O. et al. Italian guidelines for the management of irritable bowel syndrome in children and adolescents. Ital. J. Pediat, 2024, vol. 50–51, pp. 7–23.
3. Bel’mer S.V., Volynets G.V., Gorelov A.V. et al. Functional disorders of the digestive system in children. Recommendations of the Society of Pediatric Gastroenterologists, Hepatologists and Nutritionists. Part 3. Rossiyskiy vestnik perinatologii i pediatrii, 2020, vol. 65, no. 6, pp. 133–144 (in Russ.).
4. Zhang X., Jin W.W., Wang H.G. Correlation between the neuroendocrine axis, microbial species, inflammatory response, and gastrointestinal symptoms in irritable bowel syndrome. World J. Gastroenterol, 2024, vol. 30 (35), pp. 3985–3995.
5. Meng Q., Qin G., Yao S.K. et al. Differences in dietary habits of people with vs without irritable bowel syndrome and their association with symptom and psychological status: A pilot study. World J. Clin. Cases, 2021, vol. 9 (11), pp. 2487–2502.
6. Dandi Ε., Spandou E., Dalla C. et al. Τhe neuroprotective role of environmental enrichment against behavioral, morphological, neuroendocrine and molecular changes following chronic unpredictable mild stress: A systematic review. Eur. J. Neurosci, 2023, vol. 58, pp. 3003–3025.
7. Komarova O.N. Correction of motility disorders in functional disorders of the digestive system in children. RMZh. Meditsinskoe obozrenie, 2019, no. 3, pp. 14–18 (in Russ.).
8. Canakis A., Haroon M., Weber H.C. Irritable bowel syndrome and gut microbiota. Curr. Opin. Endocrinol. Diabetes Obes, 2020, vol. 27, pp. 28–35.
9. Chen M., Ruan G., Chen L. et al. Neurotransmitter and Intestinal Interactions: Focus on the Microbiota-Gut-Brain Axis in Irritable Bowel Syndrome. Front. Endocrinol. (Lausanne), 2022, vol. 13, n. 817100.
10. Staudacher H.M., Scholz M., Lomer M.C., et al. Gut microbiota associations with diet in irritable bowel syndrome and the effect of low FODMAP diet and probiotics. Clin. Nutr, 2021, vol. 40, pp. 1861–1870.
11. Ng Q.X., Soh A.Y.S., Loke W. et al. The role of inflammation in irritable bowel syndrome (IBS). J. Inflamm. Res, 2018, no. 11, pp. 345–349.
12. Xiao L., Liu Q., Luo M., et al. Gut microbiota-derived metabolites in irritable bowel syndrome. Front. Cell. Infect. Microbiol, 2021, no. 11, n. 729346.
13. Taghaddos D., Saqib Z., Bai X. et al. Post-infectious ibs following Clostridioides difficile infection; role of microbiota and implications for treatment. Dig. Liver Dis, 2024, vol. 56 (11), pp. 1805–1809.
14. Beatty J.K., Bhargava A., Buret A.G. Post-infectious irritable bowel syndrome: mechanistic insights into chronic disturbances following enteric infection. World J. Gastroenterol, 2014, vol. 20 (14), pp. 3978–3985.
15. Thabane M., Kottachchi D.T., Marshall J.K. Systematic review and metaanalysis: the incidence and prognosis of post-infectious irritable bowel syndrome. Aliment. Pharmacol. Ther, 2007, vol. 26, pp. 535–544.
16. Jalanka-Tuovinen J., Saloj€arvi J., Salonen A. et al. Faecal microbiota composition and host-microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndrome. Gut, 2014, vol. 63, pp. 1737–1745.
17. Sundin J., Rangel I., Kumawat A.K. et al. Aberrant mucosal lymphocyte number and subsets in the colon of postinfectious irritable bowel syndrome patients. Scand. J. Gastroenterol, 2014, vol. 49, pp. 1068–1075.
18. Ford A.C., Lacy B.E., Talley N.J. Irritable bowel syndrome. N. Engl. J. Med,2017, vol. 376 (26), pp. 2566–2578.
19. Su Q., Tun H.M., Liu Q. et al. Gut microbiome signatures reflect different subtypes of irritable bowel syndrome. Gut Microbes, 2023, vol. 15, n. 2157697.
20. Altomare A., Di Rosa C., Imperia E. et al. Diarrhea predominant-irritable bowel syndrome (IBS-D): effects of different nutritional patterns on intestinal dysbiosis and symptoms. Nutrients, 2021, vol. 13 (5), p. 1506.
21. Gerasimets E.A., Rumyantsev N.A., Il’in R.S. et al. Planning of clinical trials of drugs for the treatment of irritable bowel syndrome: analysis of the Recommendations of the European Medicines Agency. Regulyatornye issledovaniya i ekspertiza lekarstvennykh sredstv, 2024, vol. 14, no. 4, pp. 463–473 (in Russ.).
22. Bel’mer S.V. Irritable bowel syndrome in children and intestinal microbiota: pathogenetic aspects and clinical guidelines. Meditsinskiy sovet, 2023, vol. 17, no. 17, pp. 143–148 (in Russ.).
23. Privorotskiy V.F., Luppova N.E. Irritable bowel syndrome in children: basic information and modern paradigm. Farmateka, 2018, part 4, pp. 17–24 (in Russ.).
24. Ipatov A.A., Ipatova M.G. Correction of functional gastrointestinal disorders in children. Focus on restoring intestinal microecology and motility. Meditsinskiy sovet, 2021, no. 1, pp. 125–132 (in Russ.).
25. Ganziy E.B., Voloshina L.G., Babadzhanyan E.N. et al. Optimization of treatment of irritable bowel syndrome in children. Zdorov’e rebenka, 2019, vol. 14, pp. 77–82 (in Russ.).
26. Kil’diyarova R.R. Functional gastrointestinal disorders in childhood. Smolenskiy meditsinskiy al’manakh, 2020, no. 2, pp. 184–190 (in Russ.).
27. Chey W.D. Food: the main course to wellness and illness in patients with irritable bowel syndrome. Am. J. Gastroenterol, 2016, vol. 111 (3), pp. 366–371.
28. Dicheva D.T., Andreev D.N., Shcheglanova M.P. et al. Irritable bowel syndrome in light of the Rome criteria revision IV (2016). Meditsinskiy sovet, 2018, no. 3, pp. 60–66 (in Russ.).
29. Eswaran S.L., Chey W.D., Han-Markey T. et al. A randomized controlled trial comparing the low FODMAP diet vs. modified NICE guidelines in US adults with IBS-D. Am. J. Gastroenterol, 2016, vol. 111, pp. 1824–1832.
30. Bohn L., Störsrud S., Liljebo T. et al. Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial. Gastroenterology, 2015, vol. 149, pp. 1399–1407.
31. Staudacher H.M., Lomer M.C.E., Anderson J.L. et al. Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J. Nutr, 2012, vol. 142, pp. 1510–1518.
32. Chong P.P, ChinV.K., Looi C.Y. et al. Themicrobiome and irritable bowel syndromea review on the pathophysiology, current research and future therapy. Front. Microbiol, 2019, no. 10, pp. 1–23.
33. El-Salhy M., Gundersen D. Diet in irritable bowel syndrome. Nutr. J, 2015, vol. 14, p. 36.
34. Morariu I.-D., Avasilcai L., Vieriu M. et al. Effects of a Low-FODMAP Diet on Irritable Bowel Syndrome in Both Children and Adults A Narrative Review. Nutrients, 2023, vol. 15, p. 2295.
35. Smirnova G.I., Korsunskiy A.A., Lyalikova V.B. Irritable bowel syndrome in children: new in diagnostics and treatment. Rossiyskiy pediatricheskiy zhurnal, 2016, vol. 19b, no. 5, pp. 309–318 (in Russ.).
36. Nizhevich A.A., Gimazetdinova R.Sh., Sataev V.U. et al. Modern approaches to the treatment of abdominal pain in irritable bowel syndrome in children. Vestnik poslediplomnogo obrazovaniya v sfere zdravookhraneniya, 2018, no. 4, pp. 75–79 (in Russ.).
37. Komarova O.N. Correction of motility disorders in functional disorders of the digestive organs in children. RMZh. Meditsinskoe obozrenie, 2019, no. 3, pp. 14–18 (in Russ.).